MARTINGALE ASSET MANAGEMENT L P - MERIDIAN BIOSCIENCE INC ownership

MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 162 filers reported holding MERIDIAN BIOSCIENCE INC in Q2 2013. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARTINGALE ASSET MANAGEMENT L P ownership history of MERIDIAN BIOSCIENCE INC
ValueSharesWeighting
Q4 2022$1,374,463
+5.2%
41,3870.0%0.03%
+3.8%
Q3 2022$1,306,000
-24.5%
41,387
-27.1%
0.03%
-16.1%
Q2 2022$1,730,000
-14.6%
56,811
-27.2%
0.03%
+3.3%
Q1 2022$2,026,000
+41.1%
77,992
+10.8%
0.03%
+66.7%
Q4 2021$1,436,000
+63.0%
70,363
+53.8%
0.02%
+50.0%
Q3 2021$881,000
-0.9%
45,761
+14.2%
0.01%
+20.0%
Q2 2021$889,000
-35.8%
40,056
-24.1%
0.01%
-37.5%
Q1 2021$1,385,000
+16.7%
52,755
-16.9%
0.02%
+23.1%
Q4 2020$1,187,000
-8.6%
63,470
-17.0%
0.01%
-18.8%
Q3 2020$1,299,000
-26.2%
76,465
+1.2%
0.02%
-23.8%
Q2 2020$1,760,000
+40.0%
75,568
-49.5%
0.02%
+23.5%
Q1 2020$1,257,000
-47.5%
149,624
-38.9%
0.02%
-29.2%
Q4 2019$2,394,000
-30.5%
244,918
-32.5%
0.02%
-31.4%
Q3 2019$3,443,000
+33.4%
362,736
+67.1%
0.04%
+29.6%
Q2 2019$2,580,000
-55.8%
217,098
-34.5%
0.03%
-57.1%
Q1 2019$5,837,000
+14.5%
331,402
+12.9%
0.06%
-6.0%
Q4 2018$5,097,000
+25.3%
293,502
+7.5%
0.07%
+39.6%
Q3 2018$4,067,000
-5.0%
272,902
+1.4%
0.05%
-9.4%
Q2 2018$4,281,000
+12.5%
269,200
+0.4%
0.05%
+8.2%
Q1 2018$3,806,000
+50.2%
268,000
+48.1%
0.05%
+44.1%
Q4 2017$2,534,000
+90.1%
180,990
+94.2%
0.03%
+88.9%
Q3 2017$1,333,000
-0.9%
93,175
+9.1%
0.02%
-5.3%
Q2 2017$1,345,000
+48.6%
85,369
+30.2%
0.02%
+46.2%
Q1 2017$905,000
-79.2%
65,554
-73.3%
0.01%
-78.7%
Q4 2016$4,351,000
+0.8%
245,771
+9.8%
0.06%
-4.7%
Q3 2016$4,317,000
+130.6%
223,763
+133.2%
0.06%
+106.5%
Q2 2016$1,872,000
-5.8%
95,962
-0.4%
0.03%
-20.5%
Q1 2016$1,987,0000.0%96,361
-0.5%
0.04%
-11.4%
Q4 2015$1,987,000
+19.6%
96,801
-0.3%
0.04%
+7.3%
Q3 2015$1,661,000
+54.1%
97,123
+68.0%
0.04%
+64.0%
Q2 2015$1,078,000
+34.6%
57,819
+37.8%
0.02%
+31.6%
Q1 2015$801,000
+82.5%
41,959
+57.4%
0.02%
+58.3%
Q4 2014$439,000
-6.0%
26,654
+1.2%
0.01%
-20.0%
Q3 2014$467,000
-74.2%
26,344
-70.0%
0.02%
-48.3%
Q2 2014$1,810,000
+87.0%
87,692
+97.5%
0.03%
-12.1%
Q1 2014$968,000
-7.3%
44,396
+12.8%
0.03%
-8.3%
Q4 2013$1,044,000
+9.4%
39,341
-2.5%
0.04%
+5.9%
Q3 2013$954,000
+10.2%
40,344
+0.3%
0.03%
+6.2%
Q2 2013$866,00040,2430.03%
Other shareholders
MERIDIAN BIOSCIENCE INC shareholders Q2 2013
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 115,571$3,034,0002.64%
Acuitas Investments, LLC 160,046$4,201,0002.41%
HUSSMAN STRATEGIC ADVISORS, INC. 144,000$3,780,0000.78%
GLOBEFLEX CAPITAL L P 158,664$4,165,0000.76%
CLARK ESTATES INC/NY 220,000$5,775,0000.74%
SYSTEMATIC FINANCIAL MANAGEMENT LP 721,176$18,931,0000.69%
EARNEST PARTNERS LLC 4,341,834$113,973,0000.68%
MOODY ALDRICH PARTNERS LLC 138,844$3,645,0000.53%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 889,269$23,343,0000.49%
Phocas Financial Corp. 134,740$3,537,0000.47%
View complete list of MERIDIAN BIOSCIENCE INC shareholders